Depression and cardiovascular disease: selected findings, controversies, and clinical implications from 2009

Karina W Davidson1, Maya Rom Korin

  • 1Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. kd2124@columbia.edu

Insights

In 2009, studies linked antidepressant use to higher cardiovascular disease (CVD) risks. Debates continued on screening depressed patients with CVD, with evidence favoring CVD screening in depressed individuals.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Depression is a significant comorbidity with cardiovascular disease (CVD).
  • The relationship between depression and CVD outcomes remains a critical area of research.
  • Understanding the 2009 literature provides insight into evolving clinical practices and research directions.

Purpose of the Study:

  • To systematically review empirical research on depression and cardiovascular disease (CVD) published in 2009.
  • To identify and discuss notable findings and controversies in the 2009 literature.
  • To explore the clinical implications of these findings for patient care and future research.

Main Methods:

  • Systematic search of published empirical research on depression and CVD.
  • Analysis of 494 unique articles published in 2009.
  • Identification and synthesis of key findings and ongoing debates.

Main Results:

  • Multiple observational studies indicated an association between antidepressant use and increased risk of stroke, CVD, or sudden cardiac death.
  • Four randomized controlled trials (RCTs) reported significant efficacy results for depression interventions in CVD patients.
  • Controversy persisted regarding routine screening for depression in CVD patients versus screening for CVD in depressed patients.

Conclusions:

  • The 2009 literature highlighted potential risks associated with antidepressant use in CVD patients.
  • RCTs provided crucial efficacy data for depression interventions in this population.
  • The debate on appropriate screening strategies for depression and CVD in affected patients continued, with a call for evidence-based approaches.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...